By Nick Carey (Reuters) – Amazon (NASDAQ:AMZN) said on Tuesday it has ordered 200 Mercedes-Benz (OTC:MBGAF) fully-electric eActros 600 heavy goods vehicles from
By Anirban Sen, Alexandra Alper and David Shepardson (Reuters) -Cleveland-Cliffs is partnering with peer Nucor (NYSE:NUE) to prepare a potential all-cash
(Reuters) – Electricity provider Hawaiian Electric on Monday laid out a plan to fortify the power grid to help reduce the risk
NEW YORK (Reuters) – Online trading firm Robinhood Markets (NASDAQ:HOOD) has agreed to pay $45 million to settle U.S. Securities
NEW YORK (Reuters) – As multiple wildfires devour tens of thousands of acres across Los Angeles in what is expected to be the
President Biden on Monday spoke for the last time from the State Department on the state of American foreign policy and national
(Reuters) – The boards of directors of the Federal Reserve’s 12 regional banks have grown more diverse by gender and race in
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets. A sea of red across most equity markets and no
Investing.com — Markets are struggling in the wake of a surging Treasury yields on fresh fears disinflation could be stalling even as
Investing.com — The S&P 500 closed higher after cutting losses Monday as a jump in cyclical stocks including energy helped offset a
Investing.com – Russia stocks were higher after the close on Monday, as gains in the Oil & Gas, Mining and Power sectors
Investing.com – Colombia stocks were higher after the close on Monday, as gains in the Industrials, Services and Agriculture sectors led shares
Titan America SA (TTAM) has filed for a proposed IPO. The company describes itself as: “Titan America is a leading vertically integrated, multi-regional
Investing.com — Shares of Blueprint Medicines (NASDAQ:BPMC) Corporation (NASDAQ:BPMC) climbed 17% as the company outlined its growth strategy for 2025, highlighting the
By Abigail Summerville NEW YORK (Reuters) – The owners of Crumbl are exploring a sale that could value the popular cookie chain at
Investing.com — Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) fell 14% today as investors reacted to the company’s preliminary performance results and a
